Halogenated triazinediones behave as antagonist of PKR1: in -vitro and in-vivo pharmacological characterization (original) (raw)

Journal of Medicinal Chemistry, 2008

Triazinediones as prokineticin 1 receptor antagonists. Part 1: SAR, synthesis and biological evaluation

Bioorganic & Medicinal Chemistry Letters, 2009

Inhibitory effect of positively charged triazine antagonists of prokineticin receptors on the transient receptor vanilloid type-1 (TRPV1) channel

Valentina Onnis, Jae Lee, Cenzo Congiu

View PDFchevron_right

Design of Novel Neurokinin 1 Receptor Antagonists Based on Conformationally Constrained Aromatic Amino Acids and Discovery of a Potent Chimeric Opioid Agonist-Neurokinin 1 Receptor Antagonist

Joost Duppen

Journal of Medicinal Chemistry, 2011

View PDFchevron_right

3Oxo2-piperazinyl acetamides as potent bradykinin B1 receptor antagonists for the treatment of pain and inflammation

Kevin Yang

International Journal of Food Microbiology, 2011

View PDFchevron_right

1-Benzylbenzimidazoles: The discovery of a novel series of bradykinin B 1 receptor antagonists

David Wustrow

Bioorganic & Medicinal Chemistry Letters, 2008

View PDFchevron_right

Sensitization of Transient Receptor Potential Vanilloid 1 by the Prokineticin Receptor Agonist Bv8

elisa giannini

Journal of Neuroscience, 2006

View PDFchevron_right

Structure−Activity Relationships of 6-Methyl-benzo[ b ]thiophene-2-carboxylic Acid (1-{( S )-1-Benzyl-4-[4-(tetrahydropyran-4-ylmethyl)piperazin-1-yl]butylcarbamoyl}cyclopentyl)amide, Potent Antagonist of the Neurokinin-2 Receptor

Elena Marastoni

Journal of Medicinal Chemistry, 2010

View PDFchevron_right

Modeling of Human Prokineticin Receptors: Interactions with Novel Small-Molecule Binders and Potential Off-Target Drugs

Masha Niv

PLOS One, 2011

View PDFchevron_right

Orally Active Peptidic Bradykinin B1 Receptor Antagonists Engineered from a Cyclotide Scaffold for Inflammatory Pain Treatment

Clarence Wong

Angewandte Chemie International Edition, 2012

View PDFchevron_right

Inhibitory effect of positively charged triazine antagonists of prokinecitin receptors on the transient receptor vanilloid type-1 (TRPV1) channel

Cenzo Congiu, Luciano De Petrocellis, Jae Lee, Valentina Onnis, Gerald Zamponi

View PDFchevron_right

Pharmacological, Pharmacokinetic, and Primate Analgesic Efficacy Profile of the Novel Bradykinin B1 Receptor Antagonist ELN441958

Mark Dreyer

Journal of Pharmacology and Experimental Therapeutics, 2007

View PDFchevron_right

Chemical Synthesis and Structure of the Prokineticin Bv8

Irina Vetter, Rodrigo Morales

ChemBioChem, 2010

View PDFchevron_right

Recent advances in neurokinin-3 receptor antagonists

Mario Grugni

Expert Opinion on …, 2000

View PDFchevron_right

Discovery of a Novel Class of Selective Non-Peptide Antagonists for the Human Neurokinin-3 Receptor. 2. Identification of (S)-N-(1-Phenylpropyl)-3-hydroxy-2- phenylquinoline-4-carboxamide (SB 223412)

Mario Grugni

Journal of Medicinal Chemistry, 1999

View PDFchevron_right

In Vitro Cytotoxic Activities of 2-Alkyl-4,6-diheteroalkyl-1,3,5-triazines: New Molecules in Anticancer Research

Lisa Via

Journal of Medicinal Chemistry, 2004

View PDFchevron_right

Pharmacological activity of a Bv8 analogue modified in position 24

Rossella Miele, Roberta Lattanzi, Vito de Novellis

British Journal of Pharmacology, 2012

View PDFchevron_right

Bradyzide, a potent non-peptide B2bradykinin receptor antagonist with long-lasting oral activity in animal models of inflammatory hyperalgesia

László Urbán

British Journal of Pharmacology, 2000

View PDFchevron_right

Harnessing the Anti-Nociceptive Potential of NK2 and NK3 Ligands in the Design of New Multifunctional μ/δ-Opioid Agonist–Neurokinin Antagonist Peptidomimetics

Jolien De Neve

Molecules, 2021

View PDFchevron_right

Selective agonists for substance P and neurokinin receptors

P. D'Orléans-Juste

Neuropeptides, 1987

View PDFchevron_right

Novel small molecule bradykinin B1 receptor antagonists. Part 1: Benzamides and semicarbazides

Dirk Scharn

Bioorganic & Medicinal Chemistry Letters, 2010

View PDFchevron_right

Direct Phenotypic Screening in Mice: Identification of Individual, Novel Antinociceptive Compounds from a Library of 734 821 Pyrrolidine Bis-piperazines

Adel Nefzi

ACS combinatorial science, 2016

View PDFchevron_right

Discovery of a Novel Class of Selective Non-Peptide Antagonists for the Human Neurokinin-3 Receptor. 1. Identification of the 4-Quinolinecarboxamide Framework

Mario Grugni

Journal of Medicinal Chemistry, 1997

View PDFchevron_right

Synthesis and biological evaluation of compact, conformationally constrained bifunctional opioid agonist – Neurokinin-1 antagonist peptidomimetics

Joost Duppen, Olivier der Poorten, Patrycja Kleczkowska

European Journal of Medicinal Chemistry, 2015

View PDFchevron_right

Prokineticin receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database

Philippe Rondard

IUPHAR/BPS Guide to Pharmacology CITE

View PDFchevron_right

Halogenated triazinediones behave as antagonist of PKR1: in -vitro and in-vivo pharmacological characterization (original) (raw)

Related papers